At the time of drafting this Editor’s page, we were thrilled to learn that REC: Interventional Cardiology has received its very first impact factor (IF) of 1.4 in the latest edition of the Journal Citation Reports.1 This is outstanding news and the assigned IF greatly exceeds our expectations. Like many other editors before us, we have previously mentioned on past Editor’s pages the excessive and almost obsessive reliance of the current medical publication world on IF.2-6 Everything seems to revolve around this highly coveted metric, which is made public by all medical journals without exception, especially when it increases. The manuscripts published in the different sections of REC: Interventional Cardiology have significantly impacted the interventional cardiology community in Spain and abroad. Indeed, some of our articles have received numerous citations in top international journals. Likewise, consensus documents drafted by the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) have achieved significant dissemination and impact. However, despite the obvious negative aspects of IF, the truth is that it has become the most widely recognized and accepted metric to estimate the value, visibility, and impact of scientific publications. Therefore, if there is anything we would like to highlight in this Editor’s page, it...
This review explores the transformative applications of augmented reality (AR) and mixed reality (MR) technologies in interventional cardiology. The integration of these cutting-edge systems offers unprecedented potential to enhance visualization, guidance, and outcomes during complex cardiac interventional procedures. This review examines four key domains: (1) medical AR/MR systems and technological foundations; (2) clinical applications across procedures like TAVI, PCI, and electrophysiology mapping; (3) ongoing technology development and validation efforts; and (4) educational and training applications for fostering essential skills. By providing an in-depth analysis of the benefits, challenges, and future directions, this work elucidates the paradigm shift catalyzed by AR and MR in advancing interventional cardiology practices. Through meticulous exploration of technological, clinical, and educational implications, this review underscores the pivotal role of these innovative technologies in optimizing procedural guidance, improving patient outcomes, and driving innovation in cardiovascular care.
In June 2023, the first impact factor for REC: Interventional Cardiology was announced. We all received the news with great excitement, those of us who work directly on the journal as well as our authors, reviewers, and readers. The figure added to the numerous indexations already achieved by our journal. Although this was undoubtedly a great accomplishment after years of hard work and dedication, it also marked the beginning of an annual continuous review process, with a load of commitment and expectations. Once a scientific publication enters this dynamic—as it happens with annual distinctions awarded in other professional fields—the expectations on its progress introduce a certain level of anxiety concerning the annual reviews. The interim edition of Journal Citation Reports (JCR)1 was released just a few weeks prior to the drafting this “Editor’s page”. In this report, REC: Interventional Cardiology maintains its impact factor (figure 1). This is, obviously, excellent news. Figure 1. Impact factor and quartile of the interim edition of the Journal Citation Reports, and current indexing of REC: Interventional Cardiology. The new impact factor (1.2)—which is slightly lower than the year before (1.4)—suggests stability, as it is the result of a more balanced distribution of citations, with several articles generating...
At the time of writing, 4 years have gone by since REC: Interventional Cardiology made its publishing appearance for the first time. Overall, these have been very intense years due to the COVID-19 pandemic. In particular due to the uncertainty surrounding the birth of a new medical journal in today’s competitive setting. Still, we strongly believe that these 4 years have been more profitable for our young journal than we could have ever anticipated. Although we still are in the process of being included in certain citation indices, which will give us the impact metrics so attractive to authors, our journal has become established and publishes quality content on a regular basis. In this sense, and as we will be seeing next, REC: Interventional Cardiology has already been included in some citation indices and we are very close to being accepted in the most relevant ones. REC: Interventional Cardiology is the official journal of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) and stands tall as its official true means of expression. We can see that the decision to publish several consensus documents was correct as the thousands of visits received demonstrate.1,2 A couple more documents are in...
Exposure to ionizing radiation is an inherent occupational health hazard in clinical cardiology. Health risks have been reported previously, including predilection to cancer. In addition, orthopedic injury due to prolonged wearing of heavy protective lead aprons, which are mandatory to reduce radiation risk, have been extensively documented. Cardiology as a specialty has grown with rising volumes of increasingly complex procedures. This includes electrophysiological, coronary, and structural intervention, advanced heart failure/transplant management, and diagnostic imaging. Both the operator as well imaging specialists are exposed to radiation, particularly in structural interventions where interventional cardiologists and structural imagers work closely. Increasingly, women interested in cardiology may deselect the field due to radiation concerns. This expert document highlights the risks of radiation exposure in cardiology, including practical tips within various subspecialty fields such as interventional/structural cardiology, electrophysiology, imaging, advanced heart failure, and pediatric cardiology.
Autorías: José María de la Torre Hernández, Fernando Alfonso, Raúl Moreno, Soledad Ojeda, Armando Pérez de Prado, Rafael Romaguera Torres. Localización: REC: Interventional Cardiology. Nº. 4, 2025. Artículo de Revista en Dialnet.
Back in May 2019 at the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC), we presented the first issue of REC: Interventional Cardiology (figure 1). A dream we had been dreaming for years was finally coming true. And it was coming to life the way we thought was the most suitable one, as a free of charge, open-access, bilingual (Spanish and English) publication with an optimal digital and print presentation. Figure 1. Presentation of the journal in 2019. A: at the editorial office; from left to right: Iria del Río, María González Nogal, Helena Gómez-Lobo, Belén Juan, and Eva M. Cardenal. B: Official Congress of the Spanish Society of Cardiology (2019); from left to right: José M. de la Torre-Hernández, Raúl Moreno, Fernando Alfonso, and Juan Sanchis. Since then, 7 issues have been published including original articles, clinical cases, letters, review articles, clinical trial reviews, editorials, debates, and news that have covered all aspects of interventional cardiology both coronary and structural. The...
En torno a la fecha de redacción de esta Página del Editor acabamos de conocer con gran satisfacción que en la última edición del Journal Citation Reports nuestra revista, REC: Interventional Cardiology, ha recibido su primer factor de impacto (FI), siendo este de 1,41. Es sin duda una excepcional noticia, con un valor muy por encima de lo esperado. En anteriores páginas ya hemos manifestado, como otros muchos editores han hecho antes, la excesiva y casi obsesiva dependencia que la publicación médica tiene actualmente con respecto al FI2-6. Todo parece girar en torno a esta métrica tan codiciada y que todas las revistas médicas sin excepción anuncian, sobre todo cuando sube. Los manuscritos publicados en REC: Interventional Cardiology en sus diferentes categorías han tenido de por sí una gran influencia y un notable impacto en la comunidad de cardiología intervencionista de nuestro país y también de otros. De hecho, algunos de los artículos han recibido numerosas citas en las revistas de mayor prestigio internacional. En esta misma línea, los documentos de consenso elaborados por la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (ACI-SEC) han resultado un éxito en difusión e impacto. No obstante, con todos los aspectos críticos que podamos...
BACKGROUND: The use of ionizing radiation has led to advances in medical diagnosis and treatment. OBJECTIVES: The purpose of this study was to determine the risk of radiation cataractogenesis in the interventionists and staff performing various procedures in different interventional laboratories. PATIENTS AND METHODS: This cohort study included 81 interventional cardiology staff. According to the working site, they were classified into 5 groups. The control group comprised 14 professional nurses who did not work in the interventional sites. Participants were assigned for lens assessment by two independent trained ophthalmologists blinded to the study. RESULTS: The electrophysiology laboratory staff received higher doses of ionizing radiation (17.2 ± 11.9 mSv; P < 0.001). There was a significant positive correlation between the years of working experience and effective dose in the lens (P < 0.001). In general, our findings showed that the incidence of lens opacity was 79% (95% CI, 69.9-88.1) in participants with exposure (the case group) and our findings showed that the incidence of lenses opacity was 7.1% (95% CI:2.3-22.6) with the relative risk (RR) of 11.06 (P < 0.001). CONCLUSIONS: We believe that the risk of radiation-induced cataract in cardiology interventionists and staff depends on their work site. As the radiation dose increases, the prevalence of posterior eye changes increases.
majority of members, including the chair, had no relevant RWI. RWI was reviewed at the start of all meetings and conference calls and was updated as changes occurred. Relevant RWI for authors is disclosed in Appendix 1. To ensure transparency, comprehensive RWI for authors, including RWI not pertinent to this document, is available in a Supplemental Appendix. Employment information and affiliations of the peer reviewers are shown in Appendix 2. There are no RWI restrictions for participation in peer review, in the interest of encouraging comments from a variety of constituencies to ensure that a broad range of viewpoints inform final document content.
INTRODUCTION: A reduction in the number of interventional cardiology procedures has emerged as a result of the COVID-19 pandemic. A survey was performed to quantify this decrease and the impact on the management of myocardial infarction in Latin America. METHODS: A telematic survey was conducted for all countries in Latin America. Diagnostic catheterisations, coronary and structural interventions, as well as the incidence and delay to reperfusion therapy of myocardial infarction (STEMI), were recorded. Two periods were compared: from 24 February to 8 March 2020 (pre-COVID-19) and another 2‑week period that varied according to country (COVID-19). RESULTS: Responses were obtained from 79 centres in 20 countries. There was a significant decrease in the number of diagnostic procedures (-65.2%), coronary interventions (-59.4%), structural therapeutics (-86.1%) and STEMI care (-51.2%). A decrease was noted in the incidence of STEMI, but also a delay in the time to STEMI reperfusion. While there was a variation in activity in interventional cardiology between countries, patient behaviour was rather homogeneous. CONCLUSIONS: A significant reduction in healthcare activity has been noted during the COVID-19 pandemic, including STEMI care, with the risk of increased mortality and/or morbidity following STEMI. Healthcare providers should encourage patients with suspected symptoms of STEMI to call for emergency care to ensure rapid diagnosis and timely reperfusion treatment.
Last year’s Editor’s page discussed the emerging quality of our publication that celebrated its first anniversary at that time. Also, the fast and effective response of the journal at the early and confusing times of the COVID-19 crisis should be noted, publishing—in record time—consensus documents written by the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) in collaboration with other medical societies. A clear example of this was the article describing the effects of the COVID-19 pandemic on the healthcare situation in interventional cardiology in Spain that has been cited numerous times in some of today’s most prestigious medical journals.
暂无摘要（点击查看原文获取完整内容）
En mayo de 2019, coincidiendo con la reunión de la Asociación de Cardiología Intervencionista (ACI) de la Sociedad Española de Cardiología (SEC), presentamos el primer número de REC: Interventional Cardiology (figura 1). Se cumplía así un sueño albergado durante años y hecho finalmente realidad. Además, lo hacía de la forma que habíamos considerado más idónea, como publicación de acceso totalmente libre y gratuito, en formato bilingüe (español e inglés) y con una óptima presentación tanto en su versión electrónica como en su formato impreso. Figura 1. Presentación de la revista en 2019. A: en la oficina editorial; de izquierda a derecha, Iria del Río, María González Nogal, Helena Gómez-Lobo, Belén Juan y Eva M. Cardenal. B: Congreso de las Enfermedades Cardiovasculares SEC 2019; de izquierda a derecha, José M. de la Torre-Hernández, Raúl Moreno, Fernando Alfonso y Juan Sanchis. Desde entonces ya se han publicado 7 números, en los que se han presentado estudios originales, casos clínicos, imágenes, cartas, revisiones temáticas, revisiones de ensayos, artículos especiales, editoriales, debates y noticias, que han cubierto todos los aspectos del intervencionismo cardiológico, tanto coronario como estructural. Los principales protagonistas de esta andadura inicial tan satisfactoria han sido los autores, tanto aquellos que nos han enviado sus...
was 36% in the invasive management group and 55% in the noninvasive management group. Several new meta-analyses, including data from the COMPLETE trial, comparing complete vs. culprit-only revascularization in STEMI patients supported the value of complete revascularization to reduce rates of re-infarction, cardiovascular mortality, and repeat revascularization with no difference in all-cause mortality. Likewise, in patients with NSTEMI, an observational study suggested that multivessel revascularization reduced 3-year rates of major adverse cardiac events (MACE) (total death, MI, any revascularization) compared with culprit-vessel-only revascularization. However, in this study, 1-stage multivessel revascularization was not superior to multistage revascularization except in low-tointermediate risk patients.
In today's digital world the information surges with the widespread use of the internet and global communication systems. Healthcare systems are also facing digital transformations with the enhancement in the utilization of healthcare information systems, electronic records in medical, wearable, smart devices, handheld devices, and so on. A bulk of data is produced from these digital transformations. The recent increase in medical big data and the development of computational techniques in the field of cardiology enables researchers and practitioners to extract and visualize medical big data in a new spectrum. The role of medical big data in cardiology becomes a challenging task. Early decision making in cardiac healthcare system has massive potential for dropping the cost of care, refining quality of care, and reducing waste and error. Therefore, to facilitate this process a detailed report of the existing literature will be feasible to help the doctors and practitioners in decision making for the purpose of identifying and treating cardiac diseases. This detailed study will summarize results from the existing literature on big data in the field cardiac disease. This research uses the systematic literature protocol as presented by Kitchenham et al. The data was collected from the published materials from 2008 to 2018 as conference or journal publications, books, magazines and other online sources. 190 papers were included relying on the defined inclusion, exclusion, and checking the quality criteria. The current study helped to identify medical big data features, the application of medical big data, and the analytics of the big data in cardiology. The results of the proposed research shows that several studies exist that are associated to medical big data specifically to cardiology. This research summarizes and organizes the existing literature based on the defined keywords and research questions. The analysis will help doctors to make more authentic decisions, which ultimately will help to use the study as evidence for treating patients with heart related diseases.
Este es uno de esos encargos que se aceptan con la máxima alegría. Poder presentar el nacimiento de nuestro proyecto más ilusionante es, además de un placer, un lujo. Cuando iniciamos nuestra andadura como junta directiva de «la sección» —el término más usado para referirnos a nuestra Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de la Sociedad Española de Cardiología— nos comprometimos a desarrollar este proyecto.
暂无摘要（点击查看原文获取完整内容）
PURPOSE: We evaluated whether the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic was associated with changes in the pattern of acute cardiovascular admissions across European centers. METHODS: We set-up a multicenter, multinational, pan-European observational registry in 15 centers from 12 countries. All consecutive acute admissions to emergency departments and cardiology departments throughout a 1-month period during the COVID-19 outbreak were compared with an equivalent 1-month period in 2019. The acute admissions to cardiology departments were classified into 5 major categories: acute coronary syndrome, acute heart failure, arrhythmia, pulmonary embolism, and other. RESULTS: Data from 54,331 patients were collected and analyzed. Nine centers provided data on acute admissions to emergency departments comprising 50,384 patients: 20,226 in 2020 compared with 30,158 in 2019 (incidence rate ratio [IRR] with 95% confidence interval [95%CI]: 0.66 [0.58-0.76]). The risk of death at the emergency departments was higher in 2020 compared to 2019 (odds ratio [OR] with 95% CI: 4.1 [3.0-5.8], P < 0.0001). All 15 centers provided data on acute cardiology departments admissions: 3007 patients in 2020 and 4452 in 2019; IRR (95% CI): 0.68 (0.64-0.71). In 2020, there were fewer admissions with IRR (95% CI): acute coronary syndrome: 0.68 (0.63-0.73); acute heart failure: 0.65 (0.58-0.74); arrhythmia: 0.66 (0.60-0.72); and other: 0.68(0.62-0.76). We found a relatively higher percentage of pulmonary embolism admissions in 2020: odds ratio (95% CI): 1.5 (1.1-2.1), P = 0.02. Among patients with acute coronary syndrome, there were fewer admissions with unstable angina: 0.79 (0.66-0.94); non-ST segment elevation myocardial infarction: 0.56 (0.50-0.64); and ST-segment elevation myocardial infarction: 0.78 (0.68-0.89). CONCLUSION: In the European centers during the COVID-19 outbreak, there were fewer acute cardiovascular admissions. Also, fewer patients were admitted to the emergency departments with 4 times higher death risk at the emergency departments.
AIMS: The COVID-19 pandemic required a significant redeployment of worldwide healthcare resources. Fear of infection, national lockdowns and altered healthcare priorities have the potential to impact utilisation of healthcare resources for non-communicable diseases. To survey health professionals' views of the impact of the COVID-19 pandemic on the rate and timing of admission of patients with ST-elevation myocardial infarction (STEMI), the European Society of Cardiology (ESC) administered an internet-based questionnaire to cardiologists and cardiovascular nurses across 6 continents. METHODS AND RESULTS: 3101 responses were received from 141 countries across 6 continents. 88.3% responded that their country was in "total lockdown" and 7.1% in partial lockdown. 78.8% responded that the number of patients presenting with STEMI was reduced since the coronavirus outbreak and 65.2% indicated that the reduction in STEMI presentations was >40%. Approximately 60% of all respondents reported that STEMI patients presented later than usual and 58.5% that >40% of STEMI patients admitted to hospital presented beyond the optimal window for primary percutaneous intervention (PCI) or thrombolysis. Independent predictors of the reported higher rate of delayed STEMI presentation were a country in total lockdown, >100 COVID-19 cases admitted locally, and the complete restructuring of the local cardiology service. CONCLUSION: The survey indicates that the impact of COVID-19 on STEMI presentations is likely to be substantial, with both lower presentations and a higher rate of delayed presentations occurring. This has potentially important ramifications for future healthcare and policy planning in the event of further waves of this pandemic.